Virtual Reality: The study intervention will take place on the day of surgery, in the ward, once patient's pre-operative preparation has been completed. The virtual reality device will be started according to the choices made by the patient (scenario and music) for a 20 min session. During that time, the patient will be left at rest and the interactions with the patient will be limited as much as possible.
Study summary
This study will assess, on patients requesting a pharmacological premedication in the preoperative period, if virtual reality reality could reduce the request of pharmacological premedication while maintaining a good level of comfort for the patient. The aim of this study is to understand if virtual reality could reduce the need for pharmacological premedication and their associated secondary effects.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* All patients undergoing elective surgery
* Minimal age of 18-year-old
* Able to give informed consent for the study
* Requesting pharmacological premedication in the pre-operative period.
Exclusion Criteria:
* Lacking capacity or ability to complete the consent form or to respond to the required obligations linked to the study protocol
* Contraindications to pharmacological premedication
* Known cognitive dysfunction, previous history of neurological/psychiatric diseases like epilepsy
* Non Italian speaking patients
* Injuries to the head/face that would prohibit wearing headsets
* Infectious skin conditions of the head/face
* Contact isolation due to bacteria and viruses
* Symptoms of vertigo or motion sickness
* Reduced visual or auditory acuity
* Pregnancy
* Claustrophobia
Primary outcome measure(s)
Proportion of patients requiring pharmacological premedication after Virtual Reality (VR) intervention — Up to the initiation of pre-oxygenation (same day)
Trial sites (1)
Facility
City
Region
Status
Istituto Cardiocentro
Lugano
Canton Ticino
Recruiting
More Ente Ospedaliero Cantonale, Bellinzona trials in Switzerland
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.